Results for tag: "Pemphigus Vulgaris Drugs"

Pemphigus Vulgaris Drugs are a type of medication used to treat the autoimmune disorder pemphigus vulgaris. This disorder is characterized by the formation of blisters and sores on the skin and mucous membranes. Treatment typically involves the use of corticosteroids, immunosuppressants, and other drugs to reduce inflammation and suppress the immune system. In some cases, antibiotics may be prescribed to treat secondary infections. The Pemphigus Vulgaris Drugs market is a subset of the larger Immune Disorders Drugs market. This market is composed of a variety of drugs used to treat a range of autoimmune disorders, including pemphigus vulgaris. These drugs are typically prescribed by dermatologists and other healthcare professionals. Some companies in the Pemphigus Vulgaris Drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more